Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPSODI: Rimonabant in Prediabetes
NCT00325650Phase 3Terminated
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimonabant in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2006; status: terminated.
02
Drugs
rimonabant
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00325650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325650.